Table 2.
Method | Gene | Specimen | Sensitivity | Specificity | Time | Reference |
---|---|---|---|---|---|---|
multiplex PCR-immunoassay | mecA and femB | screening swabs | NA | NA | 24 h | [76] |
Multiplex PCR | 280-bp nuc-based fragment,533-bp mecA-based fragment, mecA, mecC, femB,16S rRNA, nuc | isolates | 100% | 98%-100% | 3h, 5h | [16, 23, 19, 21, 77] |
Quadriplex PCR | 16S rRNA, nuc, mecA and mupA | isolates | 100% | 100% | NA | [25] |
multiplex PCR | femA and mecA | endotracheal aspirates | NA | NA | > 6 h | [18] |
multiplex PCR | S. aureus species-specific and mecA gene segments | Nasal swabs | 96.5% | 100% | within 24 h | [78] |
triplex qPCR | mecA, femA | clinical swabs | 100% | 64% | > 6 h | [20] |